These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16024862)

  • 1. Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage; a randomised clinical trial.
    Ramezani AR; Ahmadieh H; Ghaseminejad AK; Yazdani S; Golestan B
    Br J Ophthalmol; 2005 Aug; 89(8):1041-4. PubMed ID: 16024862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
    Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
    Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
    Yeh PT; Yang CH; Yang CM
    Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage?
    Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
    Eye (Lond); 2009 Aug; 23(8):1698-701. PubMed ID: 19039332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
    Ahn J; Woo SJ; Chung H; Park KH
    Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study.
    Jirawison C; Ittipunkul N
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S136-42. PubMed ID: 22696866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tranexamic acid on postvitrectomy haemorrhage in diabetic patients.
    Laatikainen L; Summanen P; Immonen I
    Int Ophthalmol; 1987 Jun; 10(3):153-5. PubMed ID: 3596907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
    Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
    Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage.
    Cheema RA; Mushtaq J; Al-Khars W; Al-Askar E; Cheema MA
    Retina; 2010; 30(10):1646-50. PubMed ID: 20634777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entry site treatment to prevent late recurrent postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Steel DH; Connor A; Habib MS; Owen R
    Br J Ophthalmol; 2010 Sep; 94(9):1219-25. PubMed ID: 19955203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH; Chen MS
    Am J Ophthalmol; 2008 Aug; 146(2):211-217. PubMed ID: 18547539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide in eyes with recurrent postvitrectomy diabetic vitreous hemorrhage.
    Lee SY; Yoon YH; Lee HG; Chung H; Kim JG
    Am J Ophthalmol; 2006 Sep; 142(3):501-3. PubMed ID: 16935603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between severity of vitreous haemorrhage and visual outcome in primary rhegmatogenous retinal detachment.
    Yeung L; Yang KJ; Chen TL; Wang NK; Chen YP; Ku WC; Lai CC
    Acta Ophthalmol; 2008 Mar; 86(2):165-9. PubMed ID: 17995984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage.
    Farahvash MS; Majidi AR; Roohipoor R; Ghassemi F
    Retina; 2011; 31(7):1254-60. PubMed ID: 21499192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitrectomy and proliferative diabetic retinopathy. Apropos of 66 eyes].
    Bouchard O; Zech JC; Trepsat C
    J Fr Ophtalmol; 1997; 20(4):263-70. PubMed ID: 9181137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficiency of air tamponade in prevention of early recurrence of vitreal hemorrhage in diabetic patients with vitrectomy].
    Brănişteanu D; Danielescu C; Irimia A; Robu M
    Oftalmologia; 2006; 50(2):62-7. PubMed ID: 16927761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy.
    Yorston D; Wickham L; Benson S; Bunce C; Sheard R; Charteris D
    Br J Ophthalmol; 2008 Mar; 92(3):365-8. PubMed ID: 18303158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.